District Court Grants Summary Judgment and Invalidates Patent in REGENXBIO v. Sarepta Litigation
LexBlog IP
JANUARY 8, 2024
On January 5, 2024, in litigation between REGENXBIO and Sarepta Therapeutics, Judge Richard Andrews of the U.S. District Court for the District of Delaware District Court granted summary judgment for Sarepta and ruled that University of Pennsylvania’s (“Penn”) U.S. last year is ongoing. § 101. Stay tuned.
Let's personalize your content